July 8, 2019
BiondVax Pharmaceuticals enrolls first patients to test flu vaccine candidate
@BiondVax Pharmaceuticals has enrolled first participants in the second cohort of the pivotal, clinical efficacy, Phase 3 trial of the M-001 universal #flu #vaccine candidate.